Theratechnologies press release ( NASDAQ: THTX ): Q1 GAAP EPS of $0.00 misses by $0.03 .
Revenue of $19.05M (+17.2% Y/Y) misses by $1.
38M . For the first quarter of Fiscal 2025, sales of EGRIFTA SV ® reached $13.88M compared to $9.
59M in the first quarter of.